STOCK TITAN

Pacira BioSciences to Present at the 2020 BMO Prescriptions for Success Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) will present at the 2020 BMO Prescriptions for Success Healthcare Conference on June 23, 2020, at 10:00 AM ET. Interested investors can access the live audio through the company’s website, with a replay available for two weeks post-event. Pacira specializes in non-opioid pain management and regenerative health solutions, with its flagship product, EXPAREL®, a long-acting analgesic launched in April 2012. The company aims to reduce opioid reliance and recently acquired the iovera⁰ system for targeted nerve pain management.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 BMO Prescriptions for Success Healthcare Conference at 10:00 AM ET on Tuesday, June 23, 2020. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.  In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

 

 

FAQ

What date will Pacira BioSciences present at the 2020 BMO Conference?

Pacira BioSciences will present on June 23, 2020.

What time is Pacira's presentation at the BMO Healthcare Conference?

Pacira's presentation is scheduled for 10:00 AM ET.

How can investors access the presentation by Pacira BioSciences?

Investors can access the live audio via the Events page on Pacira's website.

What is EXPAREL®, the product by Pacira BioSciences?

EXPAREL® is a long-acting local analgesic launched by Pacira in April 2012.

What does the iovera⁰ system do?

The iovera⁰ system is a handheld cryoanalgesia device for targeted nerve pain management.

Pacira Biosciences Inc

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.19B
44.51M
2.15%
113.85%
11.79%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TAMPA